logo
Music In Healing: Glen Ward On The Launch Of Rhythm & Relief

Music In Healing: Glen Ward On The Launch Of Rhythm & Relief

Forbesa day ago

Glen Ward, founder of Rhythm & Relief
Nearly one in four U.S. adults suffers from chronic pain, and over 58 million Americans report symptoms of mental illness annually. A longitudinal study, commissioned by the IFPI in 2023, across 20 countries reported that over 70% of respondents use music to relieve pain. In recent years, there is growing evidence showing music's power to reduce stress, improve memory, and accelerate recovery.
The concept of music as medicine is not new—ancient civilizations used music for healing—but it's gaining renewed legitimacy through modern science. In I Heard There Was a Secret Chord, Daniel Levitin highlights that listening to music you enjoy triggers the release of the brain's natural opioids - offering a pain relieving effect. In addition to controlled studies that show that specifically designed 'positive' music increased a key immune-system antibody known as Salivary IgA by 55%.
Beyond just pain relief, the application of music in health care spreads wide and deep, however, the integration of music into the U.S. healthcare system remains undersupported—modalities like music therapy are often excluded from insurance coverage and considered 'out-of-network,' limiting access. In fact, only 20% of U.S. music therapists receive insurance reimbursements.
Launched during Mental Health Awareness Month in May 2025, Rhythm & Relief is a nonprofit on a mission to help foster the integration of music as a tool for healing. Rhythm & Relief is an advocate and fundraising engine for a coalition of U.S.-based organizations that use music therapy and intervention to address chronic pain, mental illness, trauma, and emotional hardship.
Their 'ensemble' of partner nonprofits—each chosen for its evidence-based use of music in therapy—includes Music for All Seasons, Music & Memory, Music 4 Seniors, Songwriting With: Soldiers, Sounds of Saving, and Voices of Valor. Together, they support a diverse group including: veterans, hospital patients, domestic violence victims, incarcerated individuals. These organizations provide targeted services ranging from songwriting programs for veterans to therapeutic playlists for dementia patients.
As an umbrella nonprofit, Rhythm & Relief mobilizes the music and entertainment industries to generate awareness and donations through exclusive song releases, livestream benefit concerts, and large-scale events.
Its funding model is structured for transparency and impact: 85% of all donations go directly to member organizations, with the remaining 15% allocated to operating costs. 'Rather than have all these worthy programs competing for the same charity dollars, we wanted to offer a cooperative alternative,' says founder Glen Ward. 'We believe the whole is greater than the sum of the parts.'
Rhythm & Relief debuted with an official launch event in Los Angeles featuring live music, testimonials from beneficiaries, and previews of upcoming campaigns. One highlight is a collaboration with emerging artist Jada Nikole, who will debut her new single 'Always Been You' at Prince's Celebration in June. The song, donated without solicitation, was inspired by her personal connection to the cause.
'Jada reached out on her own. She resonated with our story,' Ward explains. 'It's a testament to how powerful this mission is.'
Rhythm & Relief was started by Glen Ward, a former CEO of Virgin Entertainment Group (North America) and past chairman of NARM—now known as the Music Business Association. Ward brings over 40 years of experience in the entertainment industry, retail and consumer technology to the cause. However, Ward is no stranger to philanthropy. He previously sat on the board of Nordoff Robbins and Music For All Seasons. He currently chairs Jazz Bakery, a cultural staple in Los Angeles.
Ward's passion for music as a healing tool, draws on firsthand experiences—from watching autistic children light up during music therapy sessions to witnessing music soothe distressed hospital patients—Ward sees music not just as complementary care, but as essential. 'Music isn't just entertainment—it's intervention,' he said. Rhythm & Relief aims to do more than fund existing efforts—it seeks to shift the public conversation. As Ward explained, 'We're here to really be shouting from the rooftops and to champion that cause, so raising awareness and raising those critical dollars.'
While its current focus is U.S.-based, Rhythm & Relief plans to expand globally, starting with the UK by the end of 2025. The organization also aims to grow its network of supported nonprofits from six to more than 25 in the coming years.
Beyond funding, Rhythm & Relief positions itself as a voice for the music-as-medicine movement. Its board includes industry leaders like Carmen Murray of Title 9, Chris Scoates, and Scotty Gelade—individuals who share a belief in music's deeper purpose.
For Glen Ward, the mission is deeply personal. He's seen music unlock emotion where words fall short, and he believes its potential is still vastly untapped. Rhythm & Relief is more than a funding vehicle—it's a call to elevate music as a credible, compassionate form of care. With the right support, what begins as a note can become a movement—one that transforms lives, one song at a time.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

What RFK Jr.'s Changes to CDC Panel Mean for Vaccine Policy
What RFK Jr.'s Changes to CDC Panel Mean for Vaccine Policy

Bloomberg

time16 minutes ago

  • Bloomberg

What RFK Jr.'s Changes to CDC Panel Mean for Vaccine Policy

By , Rachel Cohrs Zhang, and Damian Garde Save Robert F. Kennedy Jr., secretary of health and human services, appointed eight new members of an expert panel that advises the federal government on immunization policy, including several vocal vaccine critics and one who identifies as an 'anti-vaxxer.' The appointments came days after Kennedy's dismissal on June 9 of all 17 members of the committee that advises the US government on vaccine safety and policy, saying that removing the entire panel was the only way to restore public confidence in immunizations.

Near-record nitrate levels in Des Moines, Iowa-area rivers threaten drinking water
Near-record nitrate levels in Des Moines, Iowa-area rivers threaten drinking water

Associated Press

time17 minutes ago

  • Associated Press

Near-record nitrate levels in Des Moines, Iowa-area rivers threaten drinking water

DES MOINES, Iowa (AP) — Local officials warned more than half a million Iowans in the state's capital city and suburbs on Thursday that near-record level of pollutants in its rivers could make drinking water dangerous if immediate steps are not taken to reduce demand. But the officials declined to explain what they believe has caused the surge in nitrate levels, which has historically been tied to runoff from farmland draining into Des Moines-area rivers. The water utility, Central Iowa Water Works, issued a first-ever ban on lawn watering for the region after seeing the highest levels of nitrates in the river water since 2013. Federal regulations require a maximum nitrate level of 10 milligrams per liter. The current level being provided to 600,000 customers is 9, local officials said. 'If we end up in a space where we're well over that … threshold, we're really going to start worrying about our pregnant women and our children under the age of six months,' said Juliann Van Liew, public health director for Polk County. Van Liew warned that could drinking water with too-high levels of nitrate could potentially cause birth defects and a condition when an infant's blood doesn't have enough oxygen, commonly known as blue baby syndrome. Tami Madsen, executive director of Central Iowa Water Works, said it is not unusual to see an increase given Iowa's 'nitrate seasons' but noted this year has been unusually high. Still, she deferred on an explanation of what is driving the higher rates. 'Unfortunately, this is a first and this is not history that anyone should be proud of,' Madsen said of the ban on lawn watering. She urged cooperation. 'If we continue on the path we're on today, where people are still choosing to water their lawn over producing water that meets safe drinking water standards, we'll be back here to talk to you all about a violation of the Safe Drinking Water Act,' Madsen said. Officials made clear the water currently meets regulations and is safe to drink. But while the water utility works to treat the water to reduce nitrate pollutants to a safe level, Des Moines metro residents' demand is higher than the amount they are able to treat. The utility said it has been treating water for 55 days, at a cost of between $14,000 and $16,000 a day. In the past, the high cost to Des Moines and the rest of Polk County has led officials to go to farmers directly, to the statehouse and to court in a tug-of-war with the state's dominant agricultural industry. The officials have long complained that nitrates and phosphorous from farm fertilizers pour off fields, leaving rivers so polluted that even the utility's sophisticated and costly equipment can't keep up with purifying. In 2015, the utility took the issue to court to ask for the millions of dollars it was being forced to spend to filter unsafe levels from drinking water taken from the Des Moines and Raccoon rivers. A judge ultimately dismissed the lawsuit against three northwest Iowa counties, ruling the issue was one for the Legislature to address. The state's Republican leaders at the time lauded the ruling, saying the lawsuit wasn't necessary to improve water quality because farmers and government subdivisions already are taking steps to ensure water quality.

FDA OKs New Next-Gen Pill for Rare Lung Cancer
FDA OKs New Next-Gen Pill for Rare Lung Cancer

WebMD

time21 minutes ago

  • WebMD

FDA OKs New Next-Gen Pill for Rare Lung Cancer

approved a first-of-its-kind oral pill to treat a rare type of advanced lung cancer that often spreads to the brain. The new drug, known as taletrectinib but sold as Ibtrozi, is meant for adults with non-small-cell lung cancer (NSCLC) that has spread or worsened and is linked to a faulty ROS1 gene. This targeted therapy offers new hope to about 3,000 people in the U.S. and over 1 million globally who are diagnosed each year with advanced ROS1-positive NSCLC. NSCLC is the most common form of lung cancer – a leading cause of cancer-related deaths. About 2% of advanced cases are ROS1-positive, which grow faster and are harder to treat. Most patients are diagnosed in their 50s, often without a history of smoking. The cancer often spreads to the brain, seen in 35% at diagnosis and nearly 50% after treatment. This makes treatment especially challenging and highlights the need for better options. The FDA's decision was based on two clinical studies of people with ROS1-positive NSCLC. One trial involved 113 people who had previously been treated with a drug similar to Ibtrozi, while the other included 157 who had not. About 85% to 90% of those new to treatment responded to Ibtrozi, and at least 63% continued to see benefits for over a year. Among those previously treated, about 52% to 62% improved, with most (up to 83%) continuing to respond for at least six months. Ibtrozi also helped shrink brain tumors in 73% of people who were new to similar treatments, and in 63% of those who had tried one before, according to a news release by Nuvation Bio, the drug's maker. "Ibtrozi's durability of response and ability to effectively penetrate the brain, coupled with a well-characterized and manageable safety profile, further addresses these critical needs for patients," said Nathan Pennell, MD, PhD, a professor of medicine at the Cleveland Clinic and an investigator of the clinical trials. Ibtrozi belongs to a class of medicines called tyrosine kinase inhibitors (TKIs). It blocks the faulty ROS1 protein, helping slow cancer growth and spread. Ibtrozi is designed to reach the brain and keep the disease under control for longer. The FDA recommends 600 mg oral Ibtrozi pills once a day on an empty stomach, with no food two hours before or after taking it. Treatment continues until the cancer worsens or side effects become too serious. The most common side effects include things like nausea, diarrhea, tiredness, and dizziness. The FDA also warns about more serious risks, like liver and lung problems, heart rhythm issues, muscle pain, and possible harm to an unborn baby. People who use the drug should tell their doctor about all medications they're taking, including over-the-counter ones – especially anything for acid reflux. Women are advised not to breastfeed during treatment and for three weeks afterward. It's also important to protect your skin from the sun while taking the drug and for at least five days after stopping it.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store